Nifty : Mujko Pehchaan Lo... InsiderB is Back !Yes, I'm Back to Tradingview !
Before the analysis, I want to thank each n everyone of you for all the love, Thank you so much for your messages & people who gave follows even when I'm not available. Thanks for the Trust & Love :)
It has been more than 100 days since I posted & from now on I will try to post more often.
Now Our Nifty analysis :
Let me put that in simple manner & if you have doubts, as usual you can comment your queries & I will try to explain.
(i) Bull run from 7900's to 9300's without any retracement (pullback) thats 16% gains in 100 days. Thats a tremendous bull run, so definitely a pullback or correction expected
(ii) Nifty forming higher high & RSI showing bearish divergence, ( Negative sentiment )
(3) People who followed Me for long time knows the Gap theory we believe : " Gaps will be always filled, No matter what "
(iv) So Gaps in the zone of 9000's will soon get filled, my expectations
(v) Check where Nifty retraced, right at 1.272 extension of previous Bear rampage.
So, in short 9000's are expected in Nifty sooner. If any alignment / format probs bear with Me, it has been long time since I posted.
I got few queries like, any signal service or mentoring or pvt.whatsapp group : No Guys, not doing any of that. But I will be here to answer all your queries :)
Note : As it has been long 100 days, I will make myself available to answer your queries in comments...
Thanks for all the Love & Support :)
Nsestocks
ATUL LTD - BUY - LONG BREAKOUT#Atul BSE:ATUL NSE:ATUL trading in #NSE and #BSE with a share price 2450 has breakout from previous resistance at 2438. On daily charts the channel has been breakout from previous resistance placed at 2438. On weekly charts it has been breakout from symmetrical triangle.
Volumes have been rising with price rise form 6 trading sessions
MACD oscillators have showing strength on the charts
The CMP is trading above 200 dma and 100 dma.
So one can Initiate Long position at CMP with a SL of 2296 for a Target of 2835.
Short on RalliesBPCL has completed Cycle wave 3 earlier this year. W5 of this cycle W3 was substantially extended.
Consequently the correction in the form of W4 would also be substantial.
As shown below in the 15 min chart, first set of ABC correction is already complete. The stock should now consolidate for next few days with upward bias.
Consequently, the strategy here should be to wait for some upward movement and short in the 680-700 Zone. This is a heavy dividend paying stock, so be alert of such corporate activity.
Note: The post is meant for educational purposes only; not a trading recommendation.
LUPIN BUY (LONG)Lupin is a BUY at CMP@1470 with SL@1420 for a target of TP@1600
Lupin gets USFDA nod to market pain relief, colonoscopy drugs and also gets FDA approval for generic Percocet tablets .
Lupin recently received FDA approval for generic Suprep Bowel Prep Kit and Suprep kit approval It may add 5% to Lupin’s EPS for FY18 earnings.
In addition the pharma major’s Goa facility has been cleared by the US FDA.
Lupin Result: Revenue grew 26% YoY to INR 44.8b Gross margin was stable QoQ at 71.0%. EBITDA rose 27% YoY to INR 12.2b with margin of 27% . EBITDA margin improvement was primarily driven by strong growth in US sales (+53% YoY, +8% QoQ; despite R&D as % of sales at 12.9%) and forex gain of INR 270m. PAT of INR 6.3b was impacted by 1% due to a high tax rate of 39%.
Lupin is a BUY at CMP@1470 with SL@1420 for a target of TP@1600






